Domestic pharmaceutical firms to focus on intensive marketing of new drugs in 2005

Published: 2004-11-11 07:00:00

Updated: 2004-11-11 07:00:00

Following a gloomy 2005 forecast of a local private think tank that Korean economy may fail to emerge from the current economic slowdown and fall into a long-term structural economic slump, a number of domestic pharmaceutical firms have a plan to stage more aggressive marketing campaign for new p...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK